Among the companies with shares expected to trade actively in Thursday's session are Accenture PLC (ACN), Signet Jewelers Ltd. (SIG) and Portola Pharmaceuticals Inc. (PTLA).

 

Accenture PLC raised its guidance for the year after the consulting company easily topped expectations in its latest quarter. Shares rose 1.15% to $108.90 in premarket trading.

 

Signet Jewelers Ltd. said its profit rose 19% in its latest quarter, with earnings beating expectations, and the company issued upbeat guidance for the year. Shares rose 2.19% to $120.60 premarket.

 

Portola Pharmaceuticals Inc. said its blood-clot treatment, an oral drug, showed no statistical difference in treating the condition than the current standard of care, an injectable blood thinner, according to the results of a phase-3 trial. Shares fell 27.95% to $20.62 premarket.

 

Finish Line Inc. (FINL) reported its profit sank 90% in the final quarter of the year as it booked a hefty write-off of its technology assets and closed stores, and issued guidance for the year sharply below expectations. Shares fell 3.91% to $18.20 premarket.

 

Ides Capital Management LP, a new activist hedge fund, is launching it first fight for board seats at Boingo Wireless Inc. (WIFI), the provider of Wi-Fi service at airports and military bases, according to people familiar with the matter.

 

American Airlines Group Inc. (AAL) said Thursday that it would raise its flight attendants' pay by about 6%, a move that comes on the heels of a decision to allow employee profit-sharing.

 

Bristol-Myers Squibb Co. (BMY) Chief Executive Giovanni Caforio received compensation valued at $15.6 million in 2015, while his predecessor's pay was valued at $8.2 million, according to a regulatory filing Wednesday. Lamberto Andreotti, one of the leaders who turned the pharmaceutical company into an immunotherapy powerhouse, retired as CEO on Aug. 3. but remains executive chairman.

 

EBay Inc. (EBAY) Chief Executive Devin N. Wenig received a total compensation package of $14.5 million for 2015, a 38% boost from the year earlier that reflected his promotion to the helm in July after the spinoff of the former PayPal payments unit.

 

H.B. Fuller Co. (FUL) on Wednesday posted better-than-expected profit for the first quarter, in part due to stronger performance of its newly formed engineering-adhesives division.

 

KB Home's (KBH) first-quarter profit surged 68% and said a healthy backlog contributed to a favorable outlook for the year.

 

Lannett Co. (LCI) on Wednesday cut its projections for the year that ends in June, citing softness in the generic drug market, competitive pressure and delays in for some of its key products and delays in launching new products.

 

Monsanto Co. (MON) named a longtime manager of its seed business to head the company's ambitious push into computerized farming services, as the unit's prior leader steps down to focus on ventures like a quinoa-focused restaurant and agricultural robots.

 

Mercury Systems Inc. (MRCY) said Wednesday that it has agreed to acquire several businesses focused on the defense electronics sector from Microsemi Corp. (MSCC) in a deal valued at $300 million.

 

Oxford Industries Inc. (OXM) on Wednesday issued guidance mostly below expectations though the apparel company reported a 11% increase in fourth-quarter profit.

 

PVH Corp. (PVH) on Wednesday reported better-than-expected fourth-quarter results but issued downbeat guidance for the year, citing the impact of currency translation, lower consumer spending and increased promotions.

 

Crane-maker Terex Corp. (TEX), which has agreed to merge with Finnish industrial-crane maker Konecranes Oyj, said China's Zoomlion Heavy Industry Science & Technology Co. (ZLIOY) has raised by $1 a share its competing offer to $31 a share. Terex said its board still recommends the merger with Konecranes.

 

Write to Maria Armental at maria.armental@wsj.com

 

(END) Dow Jones Newswires

March 24, 2016 09:29 ET (13:29 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse Portola Pharmaceuticals
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse Portola Pharmaceuticals